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Background Retroperitoneal hemorrhage (RPH) is a serious but rare complication of percutaneous coronary intervention (PCI). This study aimed 
to describe the clinical outcomes of patients (pts) who developed RPH after PCI, with focus on treatment and the value of abdominal/pelvic 
computed(CT). 
Methods Among 20,904 pts undergoing PCI, we identified 93 RPH (0.45%) confirmed by CT or surgical findings. We identified 3 groups: pts on 
refractory shock (systolic pressure <80 mm Hg ≥30 min despite fluids/vasopressors, n=16 [17.2%]); pts with transient hypotension (<30 min, 
n=34 [36.6%]); pts without hypotension (n=43 [46.2%]). The primary endpoint was the composite of in-hospital death-myocardial infarction-stroke 
(MACE).
Results Baseline characteristics were similar among the 3 groups. (Table 1) Pts on refractory shock had more bleeding quantified by CT (p<0.001), 
more red blood cell (RBC) transfusion (p<0.001) and were treated invasively more often (68.7%). MACE trended higher in pts presenting with 
refractory shock, however this difference was not significant. The volume of bleeding by CT and timing of imaging diagnosis did not correlate with 
MACE. RBC transfusion, but not clopidogrel cessation, was associated with MACE.
Conclusions RPH remains as a serious complication of PCI and is associated with high rates of morbi-mortality independently of the therapeutic 
strategy. In pts who were hemodynamically stable, RPH volume as quantified by abdominal/pelvic CT did not contribute to prognosis. 
Table 1. Baseline clinical characteristics
General population Hemodynamic status
(n=93)
No hypotension
(n=43)
Transit hypotension
(n=34)
Refractory shock
(n=16)
p value
Clinical characteristics
Age, years ± SD 65.9 ± 14.8 67.0 ± 12.2 63.0 ± 17.6 69.1 ± 14.7 0.3
Men 35 (37.6%) 16 (37.2%) 14 (41.2%) 5 (31.3%) 0.8
Diabetes 23 (24.7%) 13 (30.2%) 8 (23.5%) 2 (12.5%) 0.4
History of prior PCI 25 (29.1%) 15 (39.5%) 5 (15.2%) 5 (33.3%) 0.07
History of prior CABG 18 (19.8%) 10 (24.4%) 4 (11.4%) 4 (26.7%) 0.3
LV ejection fraction, % ± SD 46 ± 15 44 ± 15 47 ± 15 52 ± 11 0.3
Laboratory characteristics
Baseline hematocrit, % ± SD 36.6 ± 6.3 35.8 ± 6.9 38.1 ± 5.0 35.5 ± 6.4 0.2
Nadir hematocrit, % ± SD 25.1 ± 5.7 25.6 ± 5.6 25.8 ± 5.3 21.9 ± 6.3 0.06
Baseline creatinine, mg/dl ± SD 1.41 ± 1.50 1.60 ± 1.75 1.36 ± 1.49 1.00 ± 0.32 0.4
Indication for PCI
Acute MI 30 (32.3%) 11 (25.6%) 17 (48.6%) 2 (13.3%) 0.02
Unstable angina 38 (40.9%) 19 (44.2%) 10 (28.6%) 9 (60.0%) 0.1
Cardiogenic shock 3 (3.3%) 0 3 (8.6%) 0 0.1
